Immunomodulatory oligonnucleotide formulations and methods for use thereof

Details for Australian Patent Application No. 2001281267 (hide)

Owner Dynavax Technologies Corporation

Inventors Fearon, Karen, L.; Van Nest, Gary; Tuck, Stephen; Dina, Dino

Agent Davies Collison Cave

Pub. Number AU-B-2001281267

PCT Pub. Number WO2003/015816

Priority 09/927,422 10.08.01 US; 09/927,884 10.08.01 US

Filing date 13 August 2001

Wipo publication date 3 March 2003

Acceptance publication date 15 May 2008

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/35 (2006.01) Medicinal preparations containing antigens or antibodies - Allergens

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2001281267

15 May 2008 Application Accepted

  Published as AU-B-2001281267

11 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001281268-Alpha7 nicotinic receptor peptides as ligands for beta amyloid P eptides

2001281266